The Work is still in progress in this new DSpace server.
 

Sudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemia

dc.contributor.authorBuzaid, Ahmed
dc.contributor.authorAl-Amri, Ali
dc.date.accessioned2019-04-16T08:59:03Z
dc.date.accessioned2021-03-31T11:13:49Z
dc.date.available2019-04-16T08:59:03Z
dc.date.available2021-03-31T11:13:49Z
dc.date.issued2017
dc.description278-280en_US
dc.description.abstractChronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by anemia, granulocytosis and granulocytic immaturity, basophilia, thrombocytosis and splenomegaly. It is associated with a reciprocal chromosomal translocation t (q34; q11), resulting in a breakpoint cluster region-Abelson fusion gene (Philadelphia chromosome). Ophthalmic manifestations as the first and the only presentation of CML in patients are very rare. Ocular lesions in CML patients are frequently asymptomatic, and thus all patients should undergo an eye evaluation at the initial diagnosis. Here, we report a previously healthy 36-year-old Saudi male who initially presented with progressive loss of vision. On examination, he was found to have a bilateral retinal hemorrhage. The investigations revealed findings consistent with CML. The patient was treated with tyrosine kinase inhibitors, and he had complete remission, including full recovery of his vision.en_US
dc.identifier.issn1658-631X
dc.identifier.urihttp://www.sjmms.net/text.asp?2017/5/3/278/213304
dc.identifier.urihttps://repository.iau.edu.sa/handle/123456789/8157
dc.language.isoenen_US
dc.titleSudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemiaen_US
dc.typeArticleen_US

Files